Verified
ICD-10 I87.2: Venous Insufficiency (Chronic) Guide for Vascular Surgeons — Documentation & Payer Compliance Playbook
Master ICD-10 I87.2 coding for chronic venous insufficiency. Reduce denials with CEAP documentation, compression trial protocols & payer compliance strategies.
ICD-10 I87.2: Venous Insufficiency (Chronic) — The Complete Clinical Documentation & Payer Compliance Playbook
TL;DR: ICD-10 code I87.2 (Venous insufficiency, chronic, peripheral) is one of the most denial-prone codes in vascular surgery billing. Payers routinely reject vein ablation claims coded to I87.2 when the clinical note omits three critical elements: (1) CEAP classification of C2 or higher, (2) documented failure of a 6-week compression stocking trial with specific mmHg and dates, and (3) duplex reflux measured in the standing position with segment-specific thresholds (≥0.5 s superficial, ≥1.0 s deep). This playbook provides the definitive documentation framework for vascular surgery medical directors to eliminate denials, differentiate I87.2 from I83.81x appropriately, and build audit-proof prior authorization packets. Scribing.io automates every element of this workflow.
Understanding I87.2 in the Context of Chronic Venous Disease
What the AHRQ Technology Assessment Missed: The Payer-Documentation Gap
The CEAP Classification Imperative: Why Payers Deny Without It
Technical Reference: ICD-10 Documentation Standards for I87.2 vs. I83.819
Scribing.io Clinical Logic: From Denial to First-Submission Approval
Duplex Ultrasound Documentation: The Standing-Position Reflux Requirement
LCD-by-LCD Payer Compliance Matrix for Vein Ablation
Implementation Playbook for Vascular Surgery Medical Directors
Understanding I87.2 in the Context of Chronic Venous Disease
Every vascular surgery medical director has watched this scenario play out: a technically perfect endovenous ablation generates a clean-denial letter eight weeks later because the note said "chronic venous insufficiency" without a single structured data element that the payer's LCD algorithm could parse. The procedure was appropriate. The patient needed it. The revenue is still sitting in accounts receivable.
ICD-10-CM code I87.2 — Venous insufficiency (chronic) (peripheral) sits at the center of this problem. It is simultaneously the most commonly assigned code for chronic venous disease (CVD) in ambulatory vein practices and the code most frequently associated with prior authorization denials for endovenous ablation procedures (CPT 36475, 36478). Scribing.io was engineered specifically to break this cycle by enforcing payer-LCD-ready documentation at the point of clinical encounter—before the claim ever reaches the clearinghouse.
The root cause of I87.2 denials is not clinical judgment. It is specificity. I87.2 tells a payer that the patient has venous insufficiency. It communicates nothing about:
Symptom severity — pain, edema, skin changes, ulceration
Anatomic localization — which vein, which leg, which segment
Clinical classification — CEAP class (the single most important payer gatekeeper)
Conservative treatment history — compression therapy trial with dates, mmHg, and documented failure
Hemodynamic confirmation — duplex-verified reflux with duration, position, and named segment
For a vascular surgery medical director overseeing a practice or health system's vein program, the financial exposure is concrete. Current benchmarks from multi-site vein practices indicate denial rates of 15–30% when I87.2-coded ablation claims lack LCD-required documentation elements. Each denial represents $2,500–$5,000+ in at-risk revenue and 45–90 days of payment delay. Across a 20-provider vein program performing 3,000 ablations annually, a 20% denial rate at $3,800 average reimbursement represents $2.28 million in delayed or lost revenue per year.
The Scribing.io ICD-10 Documentation Library was built to transform I87.2 from a denial trigger into a properly supported, first-pass-approvable claim by enforcing discrete capture of every LCD-required field at the point of care.
What the AHRQ Technology Assessment Missed: The Payer-Documentation Gap That Costs Vein Practices Millions
The most widely referenced federal resource on chronic venous disease treatment remains the CMS Medicare Coverage Database-adjacent 2017 AHRQ Technology Assessment prepared by the Duke University Evidence-based Practice Center (Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease). While methodologically rigorous in its evaluation of comparative treatment effectiveness—covering radiofrequency ablation vs. endovenous laser ablation vs. sclerotherapy, compression therapy outcomes, and diagnostic modality accuracy—this assessment contains a critical structural blind spot that directly impacts every vascular surgery practice in the United States.
The AHRQ report does not address the documentation-to-reimbursement pipeline.
Specifically, the Technology Assessment:
Mentions CEAP classification as a disease taxonomy but never specifies that CEAP class must be discretely documented in the clinical note for payer compliance, not merely referenced in a research protocol.
Reviews compression therapy evidence but does not address the payer requirement for a documented 6-week trial with specific start and stop dates, mmHg prescription (typically 20–30 mmHg per NIH/PubMed evidence base), and adherence verification.
Acknowledges duplex ultrasound as a diagnostic tool but omits the critical payer stipulation that reflux must be measured in the standing position with segment-specific duration thresholds (≥0.5 seconds for superficial veins, ≥1.0 seconds for deep veins) and named vein segments (GSV, SSV, with laterality).
Does not differentiate between I87.2 and the I83.x family in terms of when each code is clinically and financially appropriate—a distinction that determines whether a claim is paid or denied.
The Three-Field Documentation Gap
The gap between clinical evidence and payer compliance distills into three discrete data fields absent from most vein clinic notes—and entirely absent from the AHRQ framework:
The Three-Field Documentation Gap: What the AHRQ Assessment Covered vs. What Payers Require | |||
Documentation Element | AHRQ Technology Assessment Coverage | Payer LCD Requirement | Gap Impact |
|---|---|---|---|
CEAP Classification (C2+) | Referenced as research classification taxonomy; no documentation guidance | Must be discretely recorded in clinical note with specific class (C2, C3, C4a, C4b, C5, C6) | Denial for "medical necessity not established" |
Compression Trial (6-week, with mmHg and dates) | Compression therapy reviewed for clinical effectiveness; no documentation format specified | Documented start date, stop date, prescribed mmHg (typically 20–30 mmHg), and failure/inadequate response noted | Denial for "conservative therapy not attempted or not documented" |
Duplex Reflux (standing, segment-specific, timed) | Duplex ultrasound reviewed as diagnostic modality; reflux thresholds not tied to payer requirements | Reflux duration ≥0.5 s (superficial) or ≥1.0 s (deep), measured in standing position, with named vein segment and laterality | Denial for "diagnostic criteria not met" or "insufficient objective findings" |
Scribing.io closes all three gaps simultaneously. The platform enforces discrete capture of each field at the point of documentation, not as an afterthought during billing review. This is the foundational distinction that separates LCD-ready documentation from documentation that merely describes the clinical scenario.
The CEAP Classification Imperative: Why Payers Deny Vein Ablations Without It
The CEAP (Clinical-Etiology-Anatomy-Pathophysiology) classification system, originally published in 1994 and revised by an international consensus committee in 2004 and again in 2020 (see Journal of Vascular Surgery: Venous and Lymphatic Disorders consensus update), is the international standard for chronic venous disease staging. For payer purposes, the "C" (Clinical) component is the gatekeeper for procedure authorization.
CEAP Clinical Classes and Payer Authorization Thresholds
CEAP Clinical Classification: Documentation Requirements and Payer Authorization Thresholds | |||
CEAP Class | Clinical Description | Typical Payer Authorization Status for Ablation | Required Documentation Elements |
|---|---|---|---|
C0 | No visible or palpable signs of venous disease | Not authorized | N/A |
C1 | Telangiectasias or reticular veins | Typically not authorized (considered cosmetic) | N/A for ablation |
C2 | Varicose veins (≥3 mm diameter) | Authorized with symptomatic documentation + compression trial failure | Vein diameter, symptom description, CEAP class stated, compression trial documentation, duplex reflux confirmation |
C3 | Edema without skin changes | Authorized with documentation | Edema description, CEAP class stated, compression trial documentation, duplex reflux confirmation |
C4a | Pigmentation or eczema | Authorized; stronger medical necessity | Skin change description and location, CEAP class stated, duplex reflux confirmation |
C4b | Lipodermatosclerosis or atrophie blanche | Authorized; strong medical necessity | Skin change description, CEAP class stated, duplex reflux confirmation |
C5 | Healed venous ulcer | Authorized | Ulcer history with location/dates, CEAP class stated, duplex reflux confirmation |
C6 | Active venous ulcer | Authorized; urgent medical necessity | Ulcer description (size, location, duration), CEAP class stated, duplex reflux confirmation |
The Critical Error: Omitting CEAP From the Note
The most common documentation failure is not that clinicians are unaware of CEAP—it is that the CEAP class is known but not discretely stated in the clinical note. A note that reads "Patient presents with varicose veins, bilateral lower extremities, with aching and heaviness" contains clinical information consistent with C2s (symptomatic). But unless the note explicitly states "CEAP Class: C2s" or equivalent, most payer review algorithms—and virtually all automated pre-authorization systems—will not infer it.
This is not a gray area. The AMA's CPT coding guidelines and CMS LCD articles for endovenous ablation (CPT 36475, 36478) uniformly require documented clinical severity staging. CEAP is the universally accepted staging system referenced in these LCDs.
Scribing.io addresses this by presenting a mandatory CEAP classification selector during the vein assessment workflow. The clinician selects the appropriate class, and the system embeds it as a structured data element that maps to downstream coding, prior authorization generation, and audit documentation. The encounter cannot be signed off until the CEAP field is populated.
Technical Reference: ICD-10 Documentation Standards for I87.2 and I83.819
Accurate ICD-10 code selection for chronic venous disease requires understanding the clinical distinction between I87.2 and the I83.x family—a distinction that directly determines reimbursement outcomes. For complete code definitions and mapping logic, see I87.2 — Venous insufficiency (chronic) (peripheral); I83.819 — Varicose veins of unspecified lower extremity with pain.
I87.2 — Venous Insufficiency (Chronic) (Peripheral)
ICD-10-CM Full Title: Venous insufficiency (chronic) (peripheral)
Category: I87 — Other disorders of veins
Specificity Level: Non-specific; does not indicate laterality, symptom type, or complication
Appropriate Use: When chronic venous insufficiency is documented without varicose veins as the primary clinical finding; when the diagnosis is hemodynamic venous insufficiency confirmed by duplex but the clinical presentation is predominantly insufficiency-related (edema, skin changes) rather than visible varicosities
Payer Risk Profile: High denial risk when used as the sole diagnosis for ablation procedures; routinely triggers additional documentation requests
I83.819 — Varicose Veins of Unspecified Lower Extremity With Pain
ICD-10-CM Full Title: Varicose veins of unspecified lower extremity with pain
Category: I83 — Varicose veins of lower extremities
Specificity Level: Moderate; indicates pain as a symptom, but "unspecified lower extremity" triggers specificity warnings—lateralized codes (I83.811 right, I83.812 left, I83.813 bilateral) are preferred
Appropriate Use: When the primary clinical finding is symptomatic varicose veins with pain; higher payer acceptance rate for ablation procedures than I87.2 because the code inherently communicates symptomatology
Payer Risk Profile: Lower denial risk than I87.2 but still requires CEAP, compression trial, and duplex documentation to meet LCD thresholds
Decision Logic: When to Use I87.2 vs. I83.81x
ICD-10 Code Selection Matrix for Chronic Venous Disease Documentation | |||
Clinical Scenario | Correct Primary Code | Supporting Codes | Key Documentation Requirement |
|---|---|---|---|
Symptomatic varicose veins with pain, right leg | I83.811 | I87.2 (if concurrent CVI documented) | CEAP C2s+, compression trial, standing duplex with GSV reflux |
CVI with edema and skin changes, no visible varicosities | I87.2 | L97.x (if ulcer present) | CEAP C3+ or C4+, duplex reflux, compression trial |
Varicose veins with edema, left leg | I83.812 | I87.2 | CEAP C2-C3, compression trial, standing duplex with reflux |
Post-thrombotic syndrome with CVI | I87.01x (post-thrombotic) | I87.2 | DVT history documented, CEAP, duplex showing deep reflux ≥1.0 s |
Varicose veins with ulcer, right leg | I83.011 | I87.2, L97.x | CEAP C6, ulcer measurements, duplex, compression trial (if applicable) |
Scribing.io's coding engine evaluates the documented clinical findings—CEAP class, symptom type, laterality, presence of varicosities vs. isolated insufficiency—and surfaces the highest-specificity code supported by the note. When the documentation supports I83.811 (right leg, with pain) rather than I87.2, the system recommends the code swap before sign-off, along with a plain-language explanation of why the more specific code reduces denial risk. This is not upcoding; it is documentation-driven code accuracy as required by the CMS ICD-10-CM Official Guidelines for Coding and Reporting.
Scribing.io Clinical Logic: From Denial to First-Submission Approval
The following scenario demonstrates exactly how Scribing.io's documentation enforcement engine transforms a routine denial into a first-submission approval. Every step maps to a discrete system function.
The Scenario
A vein clinic schedules endovenous ablation (CPT 36475) for the right great saphenous vein (GSV). The coder submits with ICD-10 I87.2. The claim is denied because the note lacks CEAP class and does not prove a 6-week compression trial; the duplex report also omits that reflux was measured while standing. Revenue at risk: $3,800 and a 60-day delay.
Step-by-Step: How Scribing.io Prevents This Denial
Encounter Initiation — CEAP Gate Activates. When the clinician opens the vein assessment template, Scribing.io presents a mandatory CEAP classification selector. The field is not optional. The clinician evaluates the patient—varicose veins with dependent edema, no skin changes—and selects CEAP C3. The system records "CEAP Class: C3 — Edema without skin changes, right lower extremity" as a structured data element. This single field satisfies the medical necessity threshold for every major commercial LCD and the CMS NCD framework. Without it, the encounter cannot proceed to procedure scheduling.
Compression Trial Module Fires. Upon CEAP C2+ selection, Scribing.io triggers the compression trial documentation module. The system presents three mandatory fields:
Start Date: The clinician enters or imports 2026-01-15
Stop Date: 2026-02-26 (6 weeks later)
Prescription: 20–30 mmHg, knee-high
A fourth field captures the outcome: "Patient reports persistent aching, heaviness, and dependent edema despite daily wear of 20–30 mmHg knee-high compression stockings for 6 weeks. Symptoms not adequately controlled." The system calculates the interval (42 days) and validates it against the LCD minimum (≥42 days for most MACs). If the interval is <42 days, a hard stop prevents sign-off with a specific message: "Compression trial duration does not meet LCD minimum of 6 weeks. Please verify dates."
Duplex Import and Auto-Parse. The vascular lab transmits the duplex ultrasound report as an HL7 ORU message. Scribing.io ingests the report and auto-parses the critical fields:
Vein segment: Right GSV
Reflux duration: 0.8 seconds
Patient position: Standing
Segment location: Mid-thigh
The system validates: Is reflux ≥0.5 s for a superficial vein? Yes (0.8 s ≥ 0.5 s threshold). Was the measurement taken in the standing position? Yes. Is the vein segment named with laterality? Yes (Right GSV, mid-thigh). All three duplex validation checks pass. If any had failed—reflux of 0.4 s, supine position, or unnamed segment—the system would flag the deficiency and prompt the clinician to order a repeat study or amend the report.
ICD-10 Code Selection Engine. With CEAP C3, documented symptomatic varicose veins with edema, and right-leg laterality confirmed, the system evaluates the code options. The clinician's initial instinct might be I87.2 (the habitual code). But the documentation now supports I83.811 (varicose veins of right lower extremity with pain) as the primary code because varicose veins are the documented primary finding with laterality and symptoms. I87.2 is appropriate as a secondary code if the clinician also documents the underlying chronic venous insufficiency as a contributing condition. The system surfaces this recommendation: "Primary: I83.811. Documentation supports lateralized varicose veins with pain. I87.2 may be added as secondary. Switching from I87.2 to I83.811 as primary reduces denial probability based on LCD pattern analysis."
Payer-Specific Checklist Generation. Scribing.io identifies the patient's insurance carrier (e.g., Aetna, UnitedHealthcare, a specific Medicare Administrative Contractor) and pulls the corresponding LCD requirements. The system generates a checklist:
☑ CEAP class C2+ documented (C3 — confirmed)
☑ Compression trial ≥6 weeks with mmHg and dates (01/15/2026–02/26/2026, 20–30 mmHg, failed)
☑ Duplex reflux ≥0.5 s superficial, standing position (Right GSV, 0.8 s, standing, mid-thigh)
☑ Laterality documented (Right)
☑ Symptoms documented (aching, heaviness, edema)
☑ ICD-10 primary code: I83.811
☑ CPT: 36475
One-Click Prior Authorization Packet Export. The system compiles the clinical note, duplex report, compression trial documentation, CEAP classification, and payer-specific checklist into a single PDF or electronic prior authorization submission. The packet is formatted to the payer's submission requirements. Approval on first submission.
See our LCD-aware CEAP/Compression/Duplex validator that blocks sign-off until C2+ class, 6-week 20–30 mmHg dates, and standing reflux thresholds are documented—then one-click generates the prior auth packet.
Duplex Ultrasound Documentation: The Standing-Position Reflux Requirement
Duplex ultrasound documentation failures account for an estimated 25–40% of vein ablation denials, according to multi-site revenue cycle analyses from vein management organizations. The failure is almost never the quality of the ultrasound examination itself—it is the documentation of examination conditions in the report.
The Standing-Position Mandate
The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) clinical practice guidelines specify that venous reflux should be assessed with the patient in the standing position or, at minimum, in a reverse Trendelenburg position with the limb dependent. The physiologic rationale is straightforward: reflux is a gravity-dependent phenomenon. Measuring reflux in the supine position underestimates reflux duration and may produce false-negative results.
Payer LCDs have codified this clinical standard into a reimbursement requirement. A duplex report that documents reflux of 0.8 seconds but does not specify patient position is, from the payer's perspective, an incomplete study. The denial language is typically: "Duplex ultrasound report does not confirm that reflux was measured in the standing position per LCD criteria."
Segment-Specific Thresholds
Duplex Reflux Thresholds for LCD Compliance by Vein Segment | |||
Vein Type | Specific Veins | Minimum Reflux Duration | Required Documentation Elements |
|---|---|---|---|
Superficial | GSV, SSV, AASV, accessory saphenous veins | ≥0.5 seconds | Named segment, laterality, reflux duration in seconds, patient position (standing), measurement location (e.g., mid-thigh, below knee) |
Deep | Common femoral, femoral, popliteal, tibial veins | ≥1.0 seconds | Named segment, laterality, reflux duration in seconds, patient position (standing), patency status |
Perforator | Named perforator veins (e.g., Cockett, Boyd, Hunterian) | ≥0.5 seconds (with outward flow diameter ≥3.5 mm per some LCDs) | Named perforator, location (cm from reference point), diameter, reflux duration, patient position |
How Scribing.io Validates Duplex Reports
When a duplex report is imported as an HL7 ORU message or uploaded as a PDF, Scribing.io's parser extracts four critical fields: vein segment name, reflux duration, patient position, and laterality. Each field is validated against the patient's scheduled procedure and the applicable LCD. Deficiencies generate specific, actionable alerts—not generic warnings. For example:
"Duplex report documents GSV reflux of 0.8 s but does not specify patient position. LCD requires standing-position measurement. Please confirm position with vascular lab or amend report."
"Reflux duration of 0.4 s in the right GSV does not meet the ≥0.5 s superficial threshold for LCD compliance. If clinically indicated, consider repeat evaluation or document extenuating clinical circumstances."
LCD-by-LCD Payer Compliance Matrix for Vein Ablation
Local Coverage Determinations vary by Medicare Administrative Contractor (MAC) and commercial payer. The following matrix summarizes key LCD requirements for endovenous ablation across major payers, derived from publicly available LCD articles on the CMS Medicare Coverage Database.
LCD Compliance Requirements for Endovenous Ablation (CPT 36475/36478) by Payer Type | ||||
LCD Requirement | Medicare (Most MACs) | UnitedHealthcare Commercial | Aetna Commercial | Cigna Commercial |
|---|---|---|---|---|
CEAP class documented | C2+ with symptoms | C2+ with symptoms | C2+ with symptoms (some policies specify C3+) | C2+ with symptoms |
Compression trial required | 3–6 months (varies by MAC; most require minimum 6 weeks) | 6–12 weeks | 6 weeks minimum | 6 weeks minimum |
Compression mmHg documented | 20–30 mmHg minimum | 20–30 mmHg | 20–30 mmHg | 20–30 mmHg or "graduated" |
Duplex reflux threshold (superficial) | ≥0.5 s | ≥0.5 s | ≥0.5 s | ≥0.5 s |
Standing-position measurement | Required | Required or reverse Trendelenburg | Required | Required |
Named vein segment + laterality | Required | Required | Required | Required |
Symptoms documented | Pain, aching, heaviness, fatigue, swelling, skin changes, or ulcer | Same + functional impairment preferred | Same | Same |
Prior auth required | No (post-service review possible) | Yes | Yes | Yes |
Scribing.io maintains an LCD rules engine updated quarterly with published LCD revisions from all MACs and major commercial payers. When a patient's insurance is identified, the system applies the specific LCD requirements for that payer, not a generic checklist. This eliminates the common failure mode where a note satisfies one payer's LCD but not another's—particularly the MAC-specific variation in compression trial duration requirements (6 weeks vs. 3 months).
Implementation Playbook for Vascular Surgery Medical Directors
Deploying LCD-compliant documentation across a multi-provider vein program requires structural changes to four operational layers. The following playbook is designed for a vascular surgery medical director implementing Scribing.io across a practice of 5–50 providers.
Phase 1: Baseline Denial Audit (Weeks 1–2)
Pull all vein ablation denials (CPT 36475, 36478, 36482, 36483) from the trailing 12 months.
Categorize denials by root cause: missing CEAP (estimate 30–40%), missing compression trial (25–35%), duplex deficiency (20–30%), code specificity (10–15%).
Calculate total revenue at risk: (denial count) × (average reimbursement per procedure).
Identify the top 3 payers by denial volume—these become your LCD configuration priorities.
Phase 2: Vascular Lab Protocol Alignment (Weeks 2–4)
Mandate that all venous duplex reports include: patient position (standing), named vein segment with laterality, reflux duration in seconds, and measurement location.
Configure the vascular lab's reporting template to output these fields as discrete data elements in the HL7 ORU message, enabling Scribing.io auto-parsing.
Establish a re-study protocol: if a duplex report fails any of the three validation criteria upon import, the vascular lab is notified within 24 hours for amendment or repeat study before the procedure date.
Phase 3: Provider Training and Workflow Integration (Weeks 3–5)
Train all clinicians on the CEAP classification selector within Scribing.io. Emphasize that the system will hard-stop sign-off without a CEAP entry.
Walk through the compression trial module: where to enter dates, how the system calculates the 6-week interval, and what triggers a duration warning.
Demonstrate the ICD-10 code recommendation engine: how the system differentiates I87.2 from I83.81x based on documented findings, and why accepting the higher-specificity code reduces denials without altering clinical accuracy.
Run a parallel documentation exercise: have 3–5 providers document the same simulated vein case in both the legacy workflow and the Scribing.io workflow. Compare the outputs for LCD completeness.
Phase 4: Go-Live and Continuous Monitoring (Week 6+)
Key Performance Indicators for Vein Ablation Documentation Compliance | |||
KPI | Baseline Target | 90-Day Target | Measurement Source |
|---|---|---|---|
First-submission prior auth approval rate | ≥85% | ≥95% | Prior auth tracking in Scribing.io |
CEAP documentation compliance | ≥90% | 100% (hard stop enforced) | Encounter audit |
Compression trial completeness | ≥85% | ≥98% | Compression module completion rate |
Duplex report LCD validation pass rate | ≥80% | ≥95% | ORU import parse results |
I87.2 primary code usage (should decrease) | Establish baseline | Reduced by ≥40% (replaced by higher-specificity I83.81x where appropriate) | Coding dashboard |
Clean claim rate for vein ablation | ≥88% | ≥96% | Clearinghouse rejection reports |
The Revenue Recovery Calculation
For a practice performing 1,500 vein ablations annually at an average reimbursement of $3,800:
Current state (20% denial rate): 300 denials × $3,800 = $1,140,000 in delayed/lost revenue
Post-implementation target (5% denial rate): 75 denials × $3,800 = $285,000 in delayed/lost revenue
Annual revenue recovery: $855,000
This does not account for the staff time savings from eliminated appeals, reduced phone calls to payer medical directors, and the elimination of re-work in the billing office—typically estimated at 15–25 hours per week for a practice of this size.
Anchor Truth
Payers deny vein ablations coded to I87.2 unless the note documents the CEAP Class (C2 or higher) and the failure of a 6-week compression stocking trial. Scribing.io enforces payer-LCD-ready documentation by discretely capturing CEAP class (C2+), the exact 6-week compression trial dates and mmHg (20–30), and the duplex reflux detail that most denials hinge on—reflux measured in the standing position with segment-specific thresholds (≥0.5 s superficial, ≥1.0 s deep) and named vein segment (GSV/SSV, laterality). These fields map to the correct ICD-10 family (I87.2 vs. I83.81x) and assemble a pre-auth/audit packet automatically.
Stop losing $3,800 per procedure to documentation gaps that take 90 seconds to fill. Start with Scribing.io.
